MedPath

Homoeopathic medicines for the treatment of Insomnia.

Phase 2
Conditions
Health Condition 1: G470- Insomnia
Registration Number
CTRI/2023/09/057225
Lead Sponsor
axmiben Homoeopathy Institute and Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects who have been diagnosed as per the DSM-V Diagnostic Criteria for Insomnia.

2.Subjects will be selected irrespective of their sex, socio-economic status, and occupation.

3.Age between 18 to 50 years.

4.If the subject is illiterate then the relatives or family members will be assessed to fill the sleep diary.

5.Subjects who are willing to participate and sign the written informed consent form.

Exclusion Criteria

1.Subjects suffering from the complications of insomnia.

2.Subjects are undergoing treatment with non-steroidal anti-inflammatory drugs (NSAIDs), antiemetics, triptans, ergot alkaloids, and estrogen for 2 weeks prior to enrollment in the study.

3.Subjects suffering from uncontrolled systemic illness or psychiatric diseases and/or life-threatening infections.

4.Substance abuse and/or dependence.

5.Pregnant or lactating women.

6.Subjects already undergoing homoeopathic treatment elsewhere for any chronic disease within the last 02 months.

7.Non-compliance to the study treatment/ protocol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Consensus Sleep Diary CoreTimepoint: At baseline, every month, up to 6 months
Secondary Outcome Measures
NameTimeMethod
Insomnia Severity Index (ISI)Timepoint: At basline, 03 Months, 06 Months;WHOQOL-BREFTimepoint: At basline, 03 Months, 06 Months
© Copyright 2025. All Rights Reserved by MedPath